J Ampe

<i>TP53</i> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

Bram De Laere, Steffi Oeyen, Markus Mayrhofer et al. · Clinical Cancer Research · 2018 · 171 citations · Full text

Medicine, Oncology, Pharmacology +17

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Markus Mayrhofer, Bram De Laere, Tom Whitington et al. · Genome Medicine · 2018 · 132 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Circulating tumor cells and survival in abiraterone‐ and enzalutamide‐treated patients with castration‐resistant prostate cancer

Bram De Laere, Steffi Oeyen, Peter Van Oyen et al. · The Prostate · 2018 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Markus Mayrhofer, Bram De Laere, Tom Whitington et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2018 · 21 citations · Full text

Medicine, Molecular Genetics, Oncology +17

[Benign retroperitoneal pelvic schwannoma. Apropos of 2 cases].

B Rattier, B Desrousseaux, Dereux Hj et al. · PubMed · 1990 · 13 citations

Medicine, Oncology, Urology +7